ClinicalTrials.Veeva

Menu

CMR Features in Patients With Suspected Myocarditis (CMRMyo)

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Outcome, Fatal

Treatments

Diagnostic Test: CMR

Study type

Observational

Funder types

Other

Identifiers

NCT03470571
CMR Myocarditis

Details and patient eligibility

About

Presentation of myocarditis is heterogeneous, often ranges from being asymptomatic, to chest pain, dyspnoea, palpitations, and even sudden cardiac death. Diagnosing myocarditis is challenging with no current uniform clinical gold-standard. CMR is a key investigative tool, however the predictive value of CMR features is unknown. In this study we assess 670 consecutive patients with suspected myocarditis who were referred for CMR between 2002 and 2015 at the BWH. CMR features such as late gadolinium sizing, T1 mapping, extracellular volume fraction assessment, strain analysis (feature tracking), clinical data, labortory tetsings and electrocardiogramm are linked to the outcome in order to assess its predictive value.

Enrollment

670 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • patients referred by their treating physician to undergo CMR for "suspected myocarditis" as the primary clinical question

Exclusion criteria

  • evidence of coronary artery disease
  • hypertrophic cardiomyopathy
  • arrhythmogenic right ventricular cardiomyopathy
  • cardiac sarcoidosis
  • cardiac amyloidosis
  • takotsubo cardiomyopathy
  • constrictive pericarditis
  • Loeffler endocarditis
  • ventricular non-compaction
  • cardiac tumor
  • pulmonary embolism
  • severe valve disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems